In addition to the increased lifetime risk of PCa, the germline mutations in BRCA1 or BRCA2 can increase its aggressiveness [68,69,70], with the additional activation of MYC from gene amplification in combination with the inactivation of p53 and PTEN [71,72]. This evidence concerns the gene TP53 and posterior cortical atrophy.